{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:18:41Z","timestamp":1784931521141,"version":"3.55.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138332","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T18:12:43Z","timestamp":1443031963000},"page":"e0138332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"umin000002593","registry":"10.18810\/umin-japan"}],"author":[{"given":"Kentaro","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Kohro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ashidate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyoshi","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"RESEARCH Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"RC Turner","year":"1998","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"PM Kearney","year":"2008","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)","volume":"34","author":"L Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988\u20132010","volume":"36","author":"S Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"ref6","first-page":"1629","article-title":"The current status of medicinal therapy for hyperlipidemia-Kanazawa Lipid Assessment Survey (K-LAS) [in Japanese].","volume":"20","author":"H Mabuchi","year":"2000","journal-title":"Prog Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2169\/internalmedicine.52.0599","article-title":"Lack of goal attainment regarding the low-density lipoprotein cholesterol level in the management of type 2 diabetes mellitus","volume":"52","author":"M Hosokawa","year":"2013","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2010.10.035","article-title":"Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients","volume":"214","author":"N Katakami","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.amjcard.2005.04.019","article-title":"Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations","volume":"96","author":"MH Davidson","year":"2005","journal-title":"Am J Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1161\/01.CIR.99.22.2858","article-title":"Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease","volume":"99","author":"K Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"A Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study","volume":"49","author":"K El Harchaoui","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation","volume":"51","author":"JD Brunzell","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1742-1241.2003.tb10508.x","article-title":"Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies","volume":"57","author":"RH Knopp","year":"2003","journal-title":"Int J Clin Pract"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00125-006-0504-0","article-title":"Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: the relationship with ATP binding cassette proteins G5 and G8 and Niemann-Pick C1-like 1 mRNA","volume":"50","author":"SE Lally","year":"2007","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1476-511X-12-142","article-title":"RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale","volume":"12","author":"T Inazawa","year":"2013","journal-title":"Lipids Health Dis"},{"key":"ref17","first-page":"5","article-title":"Japan Atherosclerosis Society(JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/15257771003741323","article-title":". Effects of Three Strong Statins (Atorvastatin, Pitavastatin, and Rosuvastatin) on Serum Uric Acid Levels in Dyslipidemic Patients","volume":"29","author":"N Ogata","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1253\/circj.CJ-14-0810","article-title":"Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Lipid-lowering with highly potent statins in hyperlipidemia with type 2 diabetes patients (LISTEN) study\u2013","volume":"78","author":"H Ogawa","year":"2014","journal-title":"Circ J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/j.ijcard.2013.04.091","article-title":"Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies","volume":"168","author":"M Hu","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.ATV.0000117179.92263.08","article-title":"Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method","volume":"24","author":"T Hirano","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1373\/clinchem.2009.137489","article-title":"Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study","volume":"56","author":"M Ai","year":"2010","journal-title":"Clin Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1463-1326.2004.00420.x","article-title":"Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients","volume":"7","author":"LM Gaudiani","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2840-9-20","article-title":"Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)","volume":"9","author":"G Bardini","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1463-1326.2009.01152.x","article-title":"Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither","volume":"12","author":"S Conard","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"CD Gardner","year":"1996","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"HN Ginsberg","year":"2000","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0002-9343(93)90144-E","article-title":"Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B","volume":"94","author":"A Chait","year":"1993","journal-title":"Am J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(00)00484-6","article-title":"Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study","volume":"154","author":"JR McNamara","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2003.09.074","article-title":"Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus","volume":"43","author":"H Fukushima","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2011.03.012","article-title":"Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes","volume":"217","author":"L Bozzetto","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2169\/internalmedicine.39.540","article-title":"Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels","volume":"39","author":"H Masuoka","year":"2000","journal-title":"Internal Medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","article-title":"The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin","volume":"48","author":"DE Telford","year":"2007","journal-title":"J Lipid Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2006.01.024","article-title":"The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort","volume":"190","author":"T Okamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/STROKEAHA.109.564708","article-title":"Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study","volume":"41","author":"Y Doi","year":"2010","journal-title":"Stroke"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.amjmed.2005.11.015","article-title":"Contemporary management of dyslipidemia in high-risk patients: targets still not met","volume":"119","author":"AT Yan","year":"2006","journal-title":"Am J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1734-1140(12)70778-8","article-title":"Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis\u2014guidelines vs. reality","volume":"64","author":"M Bo\u017centowicz-Wikarek","year":"2012","journal-title":"Pharmacol Rep"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2008.10.024","article-title":"Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk","volume":"53","author":"JG Robinson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","article-title":"Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men","volume":"112","author":"T Pischon","year":"2005","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"ref40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"NJ Stone","year":"2014","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/M13-2850","article-title":"New Cholesterol Guidelines: Has Godot Finally Arrived?","volume":"160","author":"J Downs","year":"2014","journal-title":"Ann Intern Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/M13-2805","article-title":"Concepts and Controversies: The 2013 American College of Cardiology\/American Heart Association Risk Assessment and Cholesterol Treatment Guidelines","volume":"160","author":"SS Martin","year":"2014","journal-title":"Ann Intern Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cjca.2014.01.009","article-title":"Are the ACC\/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel","volume":"30","author":"TJ Anderson","year":"2014","journal-title":"Can J Cardiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","article-title":"An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia\u2014full report","volume":"8","year":"2014","journal-title":"J Clin Lipidol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"AB Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.amjcard.2010.01.363","article-title":"Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial","volume":"105","author":"I Holme","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"C Baigent","year":"2011","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"C Baigent","year":"2005","journal-title":"Lancet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"BC Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T13:10:39Z","timestamp":1692018639000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138332"}},"subtitle":[],"editor":[{"given":"Annunziata","family":"Nusca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,23]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138332","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,23]]}}}